PHIO PHARMACEUTICALS CORP (PHIO)
US71880W5013 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 20K | 140K 600.00% | 20K -85.71% | -100.00% | 76.5M | N/A | 76.5M | |||
| EBITDA YoY % growth | -9.29M -3.57% | -7.28M 21.64% | -8.92M -22.53% | N/A 2.24% | N/A -54.01% | N/A 15.19% | N/A 6.57% | N/A | N/A | |
| EBIT YoY % growth | -9.36M -3.77% | -7.36M 21.37% | -8.99M -22.15% | -8.976M 2.22% | -14.688M -53.70% | -12.648M 15.17% | -12.24M 6.65% | -9.792M 8.47% | 64.056M 754.17% | |
| Operating Margin | -46,800.00% | -5,257.14% | -44,950.00% | N/A | N/A | N/A | -16.00% | N/A | 83.73% | |
| EPS YoY % growth | N/A | N/A | N/A 45.77% | -211.51 94.35% | -122.28 42.19% | -100.25 25.81% | -57.47 36.65% | -16.71 70.93% | 34.70 307.69% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -3.67 52.00% |
| Revenue Q2Q % growth | N/A |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -2.652M -49.58% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.54 84.99% | -4.22 | 2.68 | 63.53% |
| Q2 2024 Q2Q % growth | -3.62 | -4.68 | 1.06 | 22.68% |
| Q4 2023 Q2Q % growth | -7.65 64.58% | -11.93 | 4.28 | 35.90% |
| Q3 2023 Q2Q % growth | -10.26 63.46% | -13.13 | 2.87 | 21.84% |
| Q4 2022 Q2Q % growth | -21.60 25.93% | -29.74 | 8.14 | 27.38% |
| Q3 2022 Q2Q % growth | -28.08 7.14% | 39.66 | -67.74 | -170.81% |
| Q2 2022 Q2Q % growth | -20.52 5.00% | -34.15 | 13.63 | 39.91% |
| Q1 2022 Q2Q % growth | -20.52 -5,935.29% | -33.05 | 12.53 | 37.91% |
| Q4 2021 Q2Q % growth | -29.16 34.15% | -35.25 | 6.09 | 17.28% |
| Q3 2021 Q2Q % growth | -30.24 30.00% | -27.54 | -2.70 | -9.80% |
| Q2 2021 Q2Q % growth | -21.60 41.18% | -28.64 | 7.04 | 24.59% |
| Q4 2020 Q2Q % growth | -44.28 -886.63% | -46.27 | 1.99 | 4.30% |
| Q3 2020 Q2Q % growth | -43.20 90.91% | -41.31 | -1.89 | -4.58% |
| Q2 2020 Q2Q % growth | -36.72 92.27% | -71.05 | 34.33 | 48.32% |
| Q4 2019 Q2Q % growth | 99.24% | -4.49 | % | |
| Q3 2019 Q2Q % growth | -475.20 76.47% | -484.70 | 9.50 | 1.96% |
| Q2 2019 Q2Q % growth | -475.20 82.61% | -484.70 | 9.50 | 1.96% |
| Q4 2018 Q2Q % growth | -594.00 | -666.47 | 72.47 | 10.87% |
| Q3 2018 Q2Q % growth | -2,019.60 | -2,302.34 | 282.74 | 12.28% |
| Q2 2018 Q2Q % growth | -2,732.40 | -3,756.46 | 1,024.06 | 27.26% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 12.75M | -12.75M | -100.00% | |
| Q1 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2019 Q2Q % growth | -100.00% | % | ||
| Q2 2019 Q2Q % growth | -100.00% | % | ||
| Q1 2019 Q2Q % growth | 20K | % | ||
| Q4 2018 Q2Q % growth | 51K | -51K | -100.00% | |
| Q3 2018 Q2Q % growth | 60K | 51K | 9K | 17.65% |
| Q2 2018 Q2Q % growth | 60K | 20.4K | 39.6K | 194.12% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |